Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92


Differential regulation of SOCS genes in normal and transformed erythroid cells.

Sarna MK, Ingley E, Busfield SJ, Cull VS, Lepere W, McCarthy DJ, Wright MJ, Palmer GA, Chappell D, Sayer MS, Alexander WS, Hilton DJ, Starr R, Watowich SS, Bittorf T, Klinken SP, Tilbrook PA.

Oncogene. 2003 May 22;22(21):3221-30.


Differential roles of SOCS family members in EpoR signal transduction.

Jegalian AG, Wu H.

J Interferon Cytokine Res. 2002 Aug;22(8):853-60.


Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.

Slavova-Azmanova NS, Kucera N, Louw A, Satiaputra J, Handoko A, Singer P, Stone L, McCarthy DJ, Klinken SP, Hibbs ML, Ingley E.

Biochem J. 2014 May 1;459(3):455-66. doi: 10.1042/BJ20130903.


Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling.

Pezet A, Favre H, Kelly PA, Edery M.

J Biol Chem. 1999 Aug 27;274(35):24497-502.


Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.

Tilbrook PA, Palmer GA, Bittorf T, McCarthy DJ, Wright MJ, Sarna MK, Linnekin D, Cull VS, Williams JH, Ingley E, Schneider-Mergener J, Krystal G, Klinken SP.

Cancer Res. 2001 Mar 15;61(6):2453-8.


Gain-of-function Lyn induces anemia: appropriate Lyn activity is essential for normal erythropoiesis and Epo receptor signaling.

Slavova-Azmanova NS, Kucera N, Satiaputra J, Stone L, Magno A, Maxwell MJ, Quilici C, Erber W, Klinken SP, Hibbs ML, Ingley E.

Blood. 2013 Jul 11;122(2):262-71. doi: 10.1182/blood-2012-10-463158. Epub 2013 May 21.


Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells.

Li S, Chen S, Xu X, Sundstedt A, Paulsson KM, Anderson P, Karlsson S, Sjögren HO, Wang P.

J Exp Med. 2000 Mar 20;191(6):985-94.


Suppressors of cytokine signalling: SOCS.

Larsen L, Röpke C.

APMIS. 2002 Dec;110(12):833-44. Review.


Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.

Sharlow ER, Pacifici R, Crouse J, Batac J, Todokoro K, Wojchowski DM.

Blood. 1997 Sep 15;90(6):2175-87.


Suppressor of cytokine signalling gene expression is elevated in breast carcinoma.

Raccurt M, Tam SP, Lau P, Mertani HC, Lambert A, Garcia-Caballero T, Li H, Brown RJ, McGuckin MA, Morel G, Waters MJ.

Br J Cancer. 2003 Aug 4;89(3):524-32.


Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.

Bouscary D, Pene F, Claessens YE, Muller O, Chrétien S, Fontenay-Roupie M, Gisselbrecht S, Mayeux P, Lacombe C.

Blood. 2003 May 1;101(9):3436-43. Epub 2002 Dec 27.


Erythroid-specific activation of the distal (testis) promoter of GATA1 during differentiation of purified normal murine hematopoietic stem cells.

Migliaccio AR, Migliaccio G, Ashihara E, Moroni E, Giglioni B, Ottolenghi S.

Acta Haematol. 1996;95(3-4):229-35.


Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.

Yamamura Y, Senda H, Kageyama Y, Matsuzaki T, Noda M, Ikawa Y.

Mol Cell Biol. 1998 Mar;18(3):1172-80.


Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling.

Adams TE, Hansen JA, Starr R, Nicola NA, Hilton DJ, Billestrup N.

J Biol Chem. 1998 Jan 16;273(3):1285-7.


A family of cytokine-inducible inhibitors of signalling.

Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ.

Nature. 1997 Jun 26;387(6636):917-21.

Items per page

Supplemental Content

Support Center